(Q53510008)
Statements
A randomized, double-blind, placebo-controlled trial of a selective COX-2 inhibitor, GW406381, in patients with postherpetic neuralgia. (English)
Steve Shackelford
Richard Rauck
Steve Quessy
David Blum
Rachel Hodge
Richard Philipson
5 May 2009
10
6
654-660